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Conclusion:  
In Denmark, 14.6% of the osteoporotic  
patients remained at high risk for fracture  
despite persistent bisphosphonate treatment. 
Alternative treatments may be considered for 
patients who remain at high risk e.g. through 
inadequate response to treatment. 
Objective:  
To estimate the proportion of osteoporosis patients who remain 
at a high risk for fracture despite being compliant to bisphospho-
nate treatment. 
Material and methods:  
This case-control study is based on Danish national health regis-
try data, including data on all hospitalizations, ICD-10 code at 
admission, and performed tests. Furthermore, results from bone 
mass density (BMD) scans were collected from three of the five 
Danish regions, and aggregated with data from the registries.  
 
 
The patient group of 2,406 patients (66.3% women and 33.7% 
men) was identified as: 
 Age ≥ 50 years 
 First bisphosphonate prescription date between 
01.01.1996 and 31.12.2008, defined as index date  
 ≥12 months pre and ≥36 months post observational 
data 
 A medication possession rate ≥80% for 24 months post 
index 
 ≥1 claim of bone mineral density (BMD) test OR a frac-
ture 12 months prior to 30 days after index date 
 
‘High risk’ patients were defined as: 
 BMD t-score <-2.5 at 24-36 months after index OR  
 Any drop in BMD between index and 24-36 months OR  
 a fracture at 24-36 months following index  
 
A total of 352 high risk patients were identified, and served as 
cases. The remaining 2,054 served as controls.  
Results:  
The proportion of high risk patients despite benefit of prior 
bisphosphonate treatment in Denmark is 14.6% (14.3% for 
women and 15.2% for men).  
T-scores were significantly different at both index and follow-up 
between cases and controls (p<0.001). High risk patients were 
more likely to smoke (OR: 2.5, p<0.001), have lower plasma 
calcium and/or vitamin D (OR: 3.4, p<0.001), and were more 
frequently diagnosed with anorexia nervosa (OR: 5.9, p=0.045). 
Furthermore, the high risk patients had a significant higher 
Charlson score (p=0.014), with a relative risk of 2.33 for scores 
>8 between cases and controls.  
Copyright—illustration: Kanis, JA and Lindsay R. eds. Osteoporosis International. London: Springer London, 2006 
